ROSSARI BIOTECH LIMITED (ROSSARI)

Current Price: ₹0.00

Back to Home
Stock Performance

Quarterly Financials

Consolidated Standalone
Particulars Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Revenue from Operations 410.61 483.47 463.77 472.72 489.65 498.35 512.73 579.56 543.72 1,129.82 581.68 684.86
YOY Revenue Growth % -5.54% 13.64% 19.14% 16.3% 19.25% 3.08% 10.56% 22.6% 11.04% 126.71% 13.45% 18.17%
Other Income 2.19 1.36 3.50 0.39 0.95 0.72 0.55 1.79 1.20 2.80 0.51 19.07
Total Income 412.80 484.83 467.27 473.11 490.60 499.07 513.28 581.35 544.92 1,132.63 582.19 703.93
Total Expenses + 335.42 432.77 368.12 374.79 367.90 416.07 419.40 533.79 499.34 1,037.85 540.09 640.20
Cost of Materials Consumed 272.07 355.63 291.00 303.94 284.03 324.36 321.48 369.77 334.40 741.61 417.60 444.47
Employee Benefit Expense 24.52 27.53 26.04 25.04 28.58 32.56 35.69 35.49 37.47 75.26 40.26 39.23
Other Expenses 38.83 49.61 51.08 45.81 55.28 59.14 62.23 72.93 67.05 142.58 71.75 72.66
Operating Profit 75.19 50.70 95.65 97.92 121.75 82.28 93.33 45.77 44.38 91.98 41.59 44.66
OPM % 18.3% 10.5% 20.6% 20.7% 24.9% 16.5% 18.2% 7.9% 8.2% 8.1% 7.2% 6.5%
Profit Before Tax + 39.51 44.79 47.76 45.39 46.78 47.82 42.05 47.56 45.58 94.78 42.10 63.73
Tax Expense 10.29 11.84 13.37 11.25 11.88 12.49 10.35 13.12 11.98 24.31 9.33 17.76
Tax % 26% 26.4% 28% 24.8% 25.4% 26.1% 24.6% 27.6% 26.3% 25.6% 22.2% 27.9%
Profit After Tax 29.22 32.95 34.39 34.13 34.90 35.33 31.70 34.44 33.60 70.47 32.77 45.97
EPS (Basic) 5.30 5.97 6.23 6.18 6.32 6.39 5.73 6.22 6.07 12.76 5.92 8.30

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021
Revenue from Operations 2,080.29 1,830.56 1,655.88 1,482.97 709.35
YOY Revenue Growth % 13.64% 10.55% 11.66% 109.06% -
Other Income 4.01 7.45 5.48 12.00 9.19
Total Income 2,084.30 1,838.00 1,661.37 1,494.97 718.54
Total Expenses + 1,900.10 1,517.19 1,340.65 1,164.61 558.90
Cost of Materials Consumed 1,299.64 1,229.92 1,079.11 970.12 434.81
Employee Benefit Expense 132.33 103.13 98.62 67.93 41.98
Other Expenses 249.59 184.15 162.93 126.56 82.12
Operating Profit 180.20 313.37 315.23 318.37 150.45
OPM % 8.7% 17.1% 19% 21.5% 21.2%
Profit Before Exceptional 184.21 177.44 143.26 134.73 106.43
Exceptional Items 0.00 0.00 0.00 0.00 0.00
Profit Before Tax + 184.21 177.44 143.26 134.73 106.43
Tax Expense 47.83 46.75 36.01 37.03 26.38
Tax % 26% 26.3% 25.1% 27.5% 24.8%
Profit After Tax 136.38 130.69 107.26 97.70 80.05
EPS (Basic) 24.66 23.67 19.46 17.81 15.56

Balance Sheet

Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021
ASSETS
Non-Current Assets + 853.05 727.37 646.41 0.00 0.00
Property, Plant & Equipment 353.53 314.69 313.61 0.00 0.00
Capital Work in Progress 140.19 47.21 13.07 0.00 0.00
Non-Current Investments 0.21 0.21 0.21 0.00 0.00
Goodwill 118.71 118.71 118.71 0.00 0.00
Other Intangible Assets 126.10 144.15 151.29 0.00 0.00
Current Assets + 1,041.93 843.58 721.16 0.00 0.00
Inventories 355.08 282.33 188.48 0.00 0.00
Trade Receivables 474.50 425.13 353.66 0.00 0.00
Cash and Cash Equivalents 44.20 25.17 69.83 0.00 0.00
Current Investments 57.31 37.58 26.00 0.00 0.00
LIABILITIES & EQUITY
Total Equity 0.00 0.00 0.00 0.00 0.00
Equity Share Capital 11.07 11.05 11.03 0.00 0.00
Other Equity 1,174.38 1,036.68 904.14 0.00 0.00
Non-Current Liabilities 174.16 99.69 105.54 0.00 0.00
Current Liabilities 536.57 424.74 346.86 0.00 0.00
Total Liabilities 710.74 524.42 452.40 0.00 0.00

Cash Flow Statement

Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021
Cash from Operating Activities 137.44 43.26 152.39 29.36 0.00
Cash from Investing Activities -183.70 -103.21 -180.89 -298.88 0.00
Cash from Financing Activities 64.90 16.19 60.86 291.79 0.00
Net Increase/Decrease in Cash 19.03 -44.03 32.36 22.27 0.00